pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,033 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT785Endpoints586BioPharma Dive224onclive165BioSpace60Fierce Biotech59raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6Hematology
  • Opinion: The military’s medical corps has a serious recruitment problem
    Congress must incentivize more physicians (and their employers) to join the military medical corps, writes the former attending physician to Congress.
    STAT · 1mo ago↗ source
  • Opinion: Medical schools diversified. So where are all the diverse doctors?
    Why are residency programs disciplining and dismissing trainees in a system funded to train them?
    STAT · 1mo ago↗ source
  • STAT+: Executives reveal tech initiatives at Summa Health, eight months after General Catalyst acquisition
    Two years after General Catalyst said it was buying Ohio safety-net hospital Summa Health, executives shed light on how the “transformation” is going.
    STAT · 1mo ago
← prev
page 26 of 42
next →
6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
↗ source
  • STAT+: Medicare still won’t say how much covering obesity drugs will cost
    Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how much this will cost taxpayers.
    STAT · 1mo ago↗ source
  • The hidden history of BPC-157, a favorite MAHA peptide
    A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using peptides.
    STAT · 1mo ago↗ source
  • STAT+: No Surprises Act arbitration rule could worsen flood of provider disputes
    The arbitration process has protected patients but generated financial windfalls for some clinicians.
    STAT · 1mo ago↗ source
  • STAT+: A standing ovation for RevMed, and caution for Akeso
    ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.
    STAT · 1mo ago↗ source
  • Ultra-low doses could bring costly cancer treatments to more patients in poorer countries
    Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.
    STAT · 1mo ago↗ source
  • STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug
    Much-awaited results at ASCO show that scientists have indeed found a way to drug a "greasy ball" involved in pancreatic cancer.
    STAT · 1mo ago↗ source
  • STAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer
    A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse population.
    STAT · 1mo ago↗ source
  • STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds
    By doing hormone therapy upfront in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.
    STAT · 1mo ago↗ source
  • Akeso, Summit drug extends survival in closely watched lung cancer trial
    <figure><div><img src="https://imgproxy.divecdn.com/U1p_j9BDqJ48JLk77g8bxOnzXIh5YVNKqCXZdq4xNwI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDcxMDQzNjg0LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • ‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer
    <figure><div><img src="https://imgproxy.divecdn.com/WEayUdfuHXoOw2FpmsOFLF4yn7KYNOFOwzm5w7xXaT4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzE4Mjc5OTExLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA
    ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.
    STAT · 1mo ago↗ source
  • STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur says
    Rick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as…
    STAT · 1mo ago↗ source
  • STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
    CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.
    STAT · 1mo ago↗ source
  • STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
    Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.
    STAT · 1mo ago↗ source
  • STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
    You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here.   We’re ASCOmaxxing. Rest…
    STAT · 1mo ago↗ source
  • At ASCO, Merck makes case for a ‘cornerstone’ cancer drug
    <p>Study results accrued so far are giving Merck greater conviction that the therapy, licensed from a China-based biotech, was worth placing into a sprawling Phase 3 program.</p>
    BioPharma Dive · 1mo ago↗ source
  • Bristol Myers unveils data for one of its next-gen blood cancer drugs
    <figure><div><img src="https://imgproxy.divecdn.com/aUhcesS0eCO3NThNNqPfIC_gM2-0lSalzL7WEg-RP7g/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02ODA4MDQ3ODAuanBn.…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Trump administration seeks to overhaul federal grantmaking process, alarming researchers
    The Trump administration has released a sweeping proposal to overhaul the bedrock regulation for all federal grants.
    STAT · 1mo ago↗ source
  • Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks
    <figure><div><img src="https://imgproxy.divecdn.com/KkNxfSBTkY2VjB8ICSuee0jTuqLQfv0D9hMURCyAiqU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjI3NzEwNDcyX1h1c…
    BioPharma Dive · 1mo ago↗ source
  • Kenya court suspends U.S. plan for Ebola quarantine facility for Americans
    A court in Kenya on Friday suspended a U.S. plan to establish a quarantine facility for Americans exposed to a rare type of Ebola virus spreading in northeastern Congo.
    STAT · 1mo ago↗ source
  • Allogene CEO to step down; Agios drug fails key test
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 1mo ago↗ source
  • Can a chaotic FDA still deliver on faster drug development?
    <figure><div><img src="https://imgproxy.divecdn.com/GjzgQSCxYItE_nvCVcgr1dRWi34d0viitteF7G59vHs/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjAxMjA4MDM3LmpwZ…
    BioPharma Dive · 1mo ago↗ source